Nephros (NEPH) Cash & Equivalents Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | -2.17% |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | -25.69% |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 93.87% |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | -16.21% |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | - |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 1.85% |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 8.39% |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 6.48% |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 20.62% |
| 10 | Nephros | 38.93 Mn | 34.91 Mn | 2.99 Mn | 1.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.56% |
| Dec 31, 2025 | 14.11% |
| Sep 30, 2025 | 9.49% |
| Jun 30, 2025 | 6.68% |
| Mar 31, 2025 | -9.03% |
| Dec 31, 2024 | -18.61% |
| Sep 30, 2024 | -30.60% |
| Jun 30, 2024 | -28.08% |
| Mar 31, 2024 | -23.65% |
| Dec 31, 2023 | -19.48% |
| Sep 30, 2023 | -3.57% |
| Jun 30, 2023 | -16.79% |
| Mar 31, 2023 | -24.64% |
| Dec 31, 2022 | -4.45% |
| Sep 30, 2022 | 0.73% |
| Jun 30, 2022 | -1.08% |
| Mar 31, 2022 | 14.53% |
| Dec 31, 2021 | 15.03% |
| Sep 30, 2021 | 11.36% |
| Jun 30, 2021 | 33.44% |
| Mar 31, 2021 | 64.94% |
| Dec 31, 2020 | 55.50% |
| Sep 30, 2020 | 225.12% |
| Jun 30, 2020 | 186.06% |
| Mar 31, 2020 | 123.48% |
| Dec 31, 2019 | 147.44% |
| Sep 30, 2019 | 68.42% |
| Jun 30, 2019 | 39.17% |
| Mar 31, 2019 | 72.66% |
| Dec 31, 2018 | 54.26% |
| Sep 30, 2018 | 43.18% |
| Jun 30, 2018 | 49.77% |
| Mar 31, 2018 | 70.50% |
| Dec 31, 2017 | 19.55% |
| Dec 31, 2016 | -21.98% |
| Mar 31, 2016 | 42.35% |
| Dec 31, 2015 | 198.34% |
| Sep 30, 2015 | 70.47% |
| Jun 30, 2015 | 1.66% |
| Mar 31, 2015 | -44.73% |
| Dec 31, 2014 | -8.37% |
| Dec 31, 2013 | 34.12% |